1. Home
  2. OGE vs HALO Comparison

OGE vs HALO Comparison

Compare OGE & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OGE Energy Corp

OGE

OGE Energy Corp

HOLD

Current Price

$44.34

Market Cap

8.8B

Sector

Utilities

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$80.85

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGE
HALO
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OGE
HALO
Price
$44.34
$80.85
Analyst Decision
Buy
Buy
Analyst Count
9
12
Target Price
$47.11
$76.42
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
02-18-2026
02-18-2026
Dividend Yield
3.87%
N/A
EPS Growth
29.01
56.68
EPS
2.49
4.74
Revenue
$3,294,800,000.00
$1,242,852,000.00
Revenue This Year
$6.45
$34.54
Revenue Next Year
$4.37
$26.28
P/E Ratio
$17.65
$17.15
Revenue Growth
18.03
31.19
52 Week Low
$40.80
$47.50
52 Week High
$47.33
$81.36

Technical Indicators

Market Signals
Indicator
OGE
HALO
Relative Strength Index (RSI) 61.11 72.30
Support Level $42.93 $71.23
Resistance Level $44.54 $74.48
Average True Range (ATR) 0.74 2.47
MACD 0.11 0.88
Stochastic Oscillator 91.33 89.45

Price Performance

Historical Comparison
OGE
HALO

About OGE OGE Energy Corp

OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: